Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity

Abstract

Intravesical injection of 500 U of BTX-A in patients with neurogenic detrusor instability was shown to be an effective treatment which reduced use of oral medication, high detrusor pressure and frequency of urinary leakage during the overall study period of 26 weeks. Quality of life was also significantly improved.